Evidence-Based Interventions and Colorectal Cancer Screening Rates: The Colorectal Cancer Screening Program, 2015-2017
- PMID: 33994253
- PMCID: PMC11008572
- DOI: 10.1016/j.amepre.2021.03.002
Evidence-Based Interventions and Colorectal Cancer Screening Rates: The Colorectal Cancer Screening Program, 2015-2017
Abstract
Introduction: The Centers for Disease Control and Prevention administers the Colorectal Cancer Control Program to increase colorectal cancer screening rates among people aged 50-75 years in areas where rates are lower than state or national levels. The aim of this study is to better understand the effectiveness of specific Colorectal Cancer Control Program components.
Methods: The study population included clinics enrolled in the Colorectal Cancer Control Program during Years 1 and 2. Clinic data collected by the Centers for Disease Control and Prevention annually from 2015 to 2017 for program evaluation were used. The outcome variable was screening rate change through Program Year 2, and predictor variables were a new implementation or enhancement of evidence-based interventions and other program components. The analysis, conducted in 2020, used ordinary least square and generalized estimating equations regressions and first difference models to estimate the associations of independent variables with the outcome.
Results: Of the total 336 clinics, 50%-70% newly implemented or enhanced different evidence-based interventions. Among these, client reminders were most highly associated with the increase in screening rates (8.0 percentage points). Provider reminder was not significantly associated with any change in screening rates. Among all program components, having a colorectal cancer screening champion was most highly (8.4 percentage points) associated with screening rate change. Results from different models were slightly different but in agreement.
Conclusions: Client reminders, provider assessment and feedback, and colorectal cancer screening champions were associated with increased clinic-level colorectal cancer screening rates. Universal implementation of these strategies can substantially increase colorectal cancer screening rates in the U.S.
Copyright © 2021 American Journal of Preventive Medicine. All rights reserved.
References
-
- Kochanek KD, Murphy SL, Xu J, Arias E. Deaths: final data for 2017. Natl Vital Stat Rep. 2019;68(9):1–77. https://www.cdc.gov/nchs/data/nvsr68/nvsr68_09-508.pdf. Accessed January 8, 2020. - PubMed
-
- U.S. Preventive Services Task Force, Bibbins-Domingo K, Grossman DC, et al. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement [published correction appears in JAMA. 2016;316(5):545] [published correction appears in JAMA. 2017;317(21):2239]. JAMA. 2016;315(23):2564–2575. 10.1001/jama.2016.5989. - DOI - PubMed
-
- Warren Andersen S, Blot WJ, Lipworth L, Steinwandel M, Murff HJ, Zheng W. Association of race and socioeconomic status with colorectal cancer screening, colorectal cancer risk, and mortality in southern U.S. adults. JAMA Netw Open. 2019;2(12):e1917995. 10.1001/jamanetworkopen.2019.17995. - DOI - PMC - PubMed
-
- Colorectal cancer screening rates reach 44.1% in FQHCs in 2018. National Colorectal Cancer Roundtable, American Cancer Society. https://nccrt.org/colorectal-cancer-screening-rates-reach-44-1-in-fqhcs-.... Updated April 25, 2021. Accessed January 9, 2020.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
